Mode
Text Size
Log in / Sign up

Pseudomonas aeruginosa in Africa shows 54.4% pooled antibiotic resistance, 100% to tetracyclinesBacteria in Africa Show Full Resistance to Tetracyclines and Glycylcyclines

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider enhanced genomic surveillance and stewardship given 54.4% pooled Pseudomonas resistance in Africa.

This meta-analysis synthesized molecular epidemiology and antimicrobial resistance data from 28 studies across 13 African countries, focusing on Pseudomonas aeruginosa isolates. The pooled resistance rate across all antibiotic classes was 54.4% (95% CI: 45.6-63.0), indicating a substantial burden of resistance. Notably, resistance to tetracyclines and glycylcyclines reached 100%, although this finding was based on limited data without reported confidence intervals.

Clonal diversity analysis revealed that non-high-risk clones (non-HRCs) predominated at 67.54% (95% CI: 53.79-80.01), while high-risk clones (HRCs) accounted for 32.46% (95% CI: 19.99-46.21). Among HRCs, ST244 was the most prevalent at 47.84% (95% CI: 20.99-75.31), followed by ST773 at 31.48%. These sequence types are recognized internationally as high-risk clones associated with multidrug resistance and healthcare-associated infections.

The authors highlight that limited genomic surveillance in Africa constrains the ability to track the emergence and spread of these resistant clones. They emphasize the need for enhanced genomic surveillance and monitoring of antimicrobial resistance to inform infection control and antimicrobial stewardship strategies.

While the pooled estimates provide a regional overview, the wide confidence intervals and the lack of reported effect sizes or comparators limit the precision of these findings. As a meta-analysis of existing literature, it does not offer new clinical trial data but rather consolidates current evidence, which may be subject to publication bias and heterogeneity across studies.

How this fits prior evidence

This meta-analysis extends prior coverage linking prior antibiotic exposure and Gram-negative infections to high MDR rates in chronic liver disease by quantifying resistance in Pseudomonas aeruginosa across Africa. It confirms that Gram-negative pathogens, specifically P. aeruginosa, exhibit high resistance, with a pooled rate of 54.4%. It also addresses a gap by identifying high-risk clones (ST244, ST773) that may drive MDR spread, reinforcing the need for surveillance.

A meta-analysis of 28 studies from 13 different African countries looked at Pseudomonas aeruginosa, a bacteria that can cause infections in hospital settings. The study focused on how these bacteria behave and how they respond to various antibiotics, specifically looking at their genetic diversity and resistance patterns.

The findings show that these bacteria have a 100% resistance rate to tetracyclines and glycylcyclines. While the overall resistance rate across all antibiotic classes was 54.4%, the resistance to these specific drugs was complete. The study also identified several high-risk clones, including ST244, which was the most common high-risk clone found in the data.

Because this was a meta-analysis of existing data rather than a new clinical trial, the results reflect current trends in the region. The researchers noted that there is currently limited genomic surveillance in the area. These findings highlight a significant need for better monitoring of how bacteria develop resistance to medicine in Africa.

What this means for you:
Pseudomonas aeruginosa in Africa shows 100% resistance to tetracyclines and glycylcyclines.

Common questions

What is the resistance rate for these specific antibiotics?

The study found that Pseudomonas aeruginosa isolates in Africa showed a 100% resistance rate to both tetracyclines and glycylcyclines. This means the bacteria were not affected by these specific types of antibiotics in the samples tested.

What other resistance levels were found?

The study reported a pooled resistance rate of 54.4% across all antibiotic classes. Additionally, the research found that high-risk clones made up about 32.46% of the samples, with the ST244 clone being the most prevalent.

What are the limitations of these findings?

The study notes that there is currently limited genomic surveillance in the region. Because this was a meta-analysis of 28 existing studies rather than a new clinical trial, the results are based on previously collected data.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen that has been reported to cause a variety of nosocomial infections, partly due to its high levels of antimicrobial resistance. With limited genomic surveillance at hand, knowledge about high-risk clones and epidemiological trends in Africa has been hindered. This systematic review and meta-analysis aimed to investigate the clonal diversity of P. aeruginosa in Africa, focusing on the prevalence and geographic spread of globally recognized high-risk clones. OBJECTIVE: To synthesize molecular evidence on P. aeruginosa circulating in Africa, to describe clonal diversity, estimate the prevalence of high-risk clones, and their antimicrobial resistance characteristics. METHODS: A literature search was conducted across PubMed, Web of Science, African Journal Online, and Scopus to retrieve studies mainly on the phenotypic and genotypic characteristics of P. aeruginosa in Africa. This study did not limit the literature by publication date. A random-effects meta-analysis model was used to estimate pooled resistance rates, and subgroup analyses were performed for specific antibiotic classes and high-risk clones (HRCs) This systematic review and meta-analysis was registered in PROSPERO database (ID: CRD420251071203). RESULTS: From the initial search, 794 records were obtained, out of which 28 studies from 13 African countries met the inclusion criteria. The pooled resistance rate across all antibiotic classes was 54.4% (95% CI: 45.6-63.0), with resistance reaching 100% for tetracyclines and glycylcyclines. While non-HRCs were more prevalent (67.54%, 95% CI: 53.79-80.01), the prevalence of the HRCs was also substantial at 32.46% (95% CI: 19.99-46.21). The eBURST analysis revealed 127 sequence types in 30 clonal complexes. Egypt and Algeria contributed the highest diversity and frequency of HRCs of P. aeruginosa, with ST244 (47.84%, 95% CI 20.99-75.31) being the most prevalent HRC, followed by ST773 at 31.48%. CONCLUSION: The widespread detection of HRCs such as ST244 and ST773 in most regions in Africa highlights a critical need to enhance genomic surveillance and implement systematic monitoring of antimicrobial resistance (AMR).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.